Morath M A, Okun J G, Müller I B, Sauer S W, Hörster F, Hoffmann G F, Kölker S
Department of General Pediatrics, Division of Inherited Metabolic Diseases, University Children's Hospital Heidelberg, Im Neuenheimer Feld 150, 69120, Heidelberg, Germany.
J Inherit Metab Dis. 2008 Feb;31(1):35-43. doi: 10.1007/s10545-007-0571-5. Epub 2007 Sep 12.
In the last decades the survival of patients with methylmalonic aciduria has been improved. However, the overall outcome of affected patients remains disappointing. The disease course is often complicated by acute life-threatening metabolic crises, which can result in multiple organ failure or even death, resembling primary defects of mitochondrial energy metabolism. Biochemical abnormalities during metabolic derangement, such as metabolic acidosis, ketonaemia/ketonuria, lactic acidosis, hypoglycaemia and hyperammonaemia, suggest mitochondrial dysfunction. In addition, long-term complications such as chronic renal failure and neurological disease are frequently found. Neuropathophysiological studies have focused on various effects caused by accumulation of putatively toxic organic acids, the so-called 'toxic metabolite' hypothesis. In previous studies, methylmalonate (MMA) has been considered as the major neurotoxin in methylmalonic aciduria, whereas more recent studies have highlighted a synergistic inhibition of mitochondrial energy metabolism (pyruvate dehydrogenase complex, tricarboxylic acid cycle, respiratory chain, mitochondrial salvage pathway of deoxyribonucleoside triphosphate (dNTP)) induced by propionyl-CoA, 2-methylcitrate and MMA as the key pathomechanism of inherited disorders of propionate metabolism. Intracerebral accumulation of toxic metabolites ('trapping' hypothesis') is considered a biochemical risk factor for neurodegeneration. Secondary effects of mitochondrial dysfunction, such as oxidative stress and impaired mtDNA homeostasis, contribute to pathogenesis of these disorders. The underlying pathomechanisms of chronic renal insufficiency in methylmalonic acidurias are not yet understood. We hypothesize that renal and cerebral pathomechanisms share some similarities, such as an involvement of dicarboxylic acid transport. This review aims to give a comprehensive overview on recent pathomechanistic concepts for methylmalonic acidurias.
在过去几十年中,甲基丙二酸尿症患者的生存率有所提高。然而,受影响患者的总体预后仍然令人失望。疾病进程常因急性危及生命的代谢危机而复杂化,这可能导致多器官功能衰竭甚至死亡,类似于线粒体能量代谢的原发性缺陷。代谢紊乱期间的生化异常,如代谢性酸中毒、酮血症/酮尿症、乳酸酸中毒、低血糖和高氨血症,提示线粒体功能障碍。此外,还经常发现慢性肾衰竭和神经疾病等长期并发症。神经病理生理学研究集中在假定有毒有机酸积累所引起的各种效应,即所谓的“毒性代谢物”假说。在先前的研究中,甲基丙二酸(MMA)被认为是甲基丙二酸尿症中的主要神经毒素,而最近的研究强调了丙酰辅酶A、2-甲基柠檬酸和MMA对线粒体能量代谢(丙酮酸脱氢酶复合物、三羧酸循环、呼吸链、脱氧核糖核苷三磷酸(dNTP)的线粒体补救途径)的协同抑制是丙酸代谢遗传性疾病的关键发病机制。脑内有毒代谢物的积累(“捕获”假说)被认为是神经退行性变的生化危险因素。线粒体功能障碍的继发效应,如氧化应激和线粒体DNA稳态受损,促成了这些疾病的发病机制。甲基丙二酸尿症中慢性肾功能不全的潜在发病机制尚不清楚。我们推测肾脏和大脑的发病机制有一些相似之处,比如二羧酸转运的参与。这篇综述旨在全面概述甲基丙二酸尿症最近的发病机制概念。